Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution

• Status: Completed
• Trial end date: 2015-12-01

Summary

The purpose of this study is to evaluate AZORGA® Ophthalmic Suspension compared to COSOPT® Ophthalmic Solution for IOP-lowering efficacy in subjects with open-angle glaucoma or ocular hypertension.

• Phase: Phase 4

Details

• Lead Sponsor: Alcon, a Novartis Company
• Treatments: Brinzolamide; Dorzolamide; Maleic acid; Ophthalmic Solutions; Pharmaceutical Solutions; Timolol